BlackRock Advisors’s Alexion Pharmaceuticals ALXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$214M Sell
1,751,063
-535,828
-23% -$65.6M 0.23% 111
2016
Q3
$280M Buy
2,286,891
+1,295,520
+131% +$167M 0.3% 86
2016
Q2
$116M Sell
991,371
-27,413
-3% -$3.89M 0.12% 187
2016
Q1
$142M Sell
1,018,784
-302,034
-23% -$44.3M 0.15% 156
2015
Q4
$252M Sell
1,320,818
-182,608
-12% -$31.9M 0.27% 93
2015
Q3
$235M Buy
1,503,426
+157,434
+12% +$28.7M 0.26% 100
2015
Q2
$243M Buy
1,345,992
+181,251
+16% +$31.3M 0.27% 106
2015
Q1
$202M Sell
1,164,741
-100,701
-8% -$18.2M 0.21% 123
2014
Q4
$234M Sell
1,265,442
-89,970
-7% -$16.7M 0.25% 113
2014
Q3
$225M Sell
1,355,412
-49,437
-4% -$8.12M 0.23% 113
2014
Q2
$220M Buy
1,404,849
+238,442
+20% +$37.6M 0.22% 121
2014
Q1
$177M Buy
1,166,407
+535,161
+85% +$85.1M 0.18% 144
2013
Q4
$83.9M Buy
631,246
+234,371
+59% +$28.1M 0.08% 254
2013
Q3
$46.1M Sell
396,875
-811,517
-67% -$89M 0.05% 341
2013
Q2
$111M Buy
+1,208,392
New +$116M 0.12% 190

Other funds holding ALXN